CBC for ​​Neuroprotective

Cannabichromene (CBC) (CAS 20675-51-8)​​ is a non-psychoactive cannabinoid recognized for its potential synergistic role in the "entourage effect" and its distinct pharmacological profile. Unlike THC, it does not bind strongly to CB1 receptors but interacts with other targets such as TRPV and serotonin receptors, contributing to its studied anti-inflammatory, antimicrobial, and neurogenesis-promoting properties. Though typically found in low concentrations in cannabis cultivars, its emerging therapeutic potential makes it a compound of growing interest in neurological and inflammatory disorder research.